Table1:
Clinicopathological parameters of HNSCC patients who participated in the study.
| Clinicopathological data | ||
|---|---|---|
| Patients (n=40) | ||
| n | % | |
| Age (years) | ||
| ≤ 61 | 13 | 32.5 |
| > 61 | 27 | 67.5 |
| (range: 26–78) | ||
| Gender | ||
| male | 31 | 77.5 |
| female | 9 | 22.5 |
| Disease status | ||
| AD | 23 | 57.5 |
| NED | 17 | 42.5 |
| Primary tumor side | ||
| oral cavity | 20 | 50 |
| pharynx | 10 | 25 |
| larynx | 9 | 22.5 |
| other localization | 1 | 2.5 |
| Tumor stage | ||
| T1 | 12 | 30 |
| T2 | 12 | 30 |
| T3 | 10 | 25 |
| T4 | 6 | 15 |
| Nodal status | ||
| N0 | 18 | 45 |
| N1 | 7 | 17.5 |
| N2 | 11 | 27.5 |
| N3 | 4 | 10 |
| Distant metastasis | ||
| M0 | 40 | 100 |
| UICC stage | ||
| I | 14 | 35 |
| II | 7 | 17.5 |
| III | 13 | 32.5 |
| IV | 6 | 15 |
| HPV status (p16 IHC) | ||
| positive | 8 | 20 |
| negative | 11 | 27.5 |
| undefined | 21 | 525 |
| Alcohol consumption | ||
| yes | 25 | 62.5 |
| no | 13 | 32.5 |
| unknown | 2 | 5 |
| Tobacco consumption | ||
| yes | 28 | 70 |
| no | 11 | 27.5 |
| unknown | 1 | 2.5 |